-
Notifications
You must be signed in to change notification settings - Fork 3
Commit
This commit does not belong to any branch on this repository, and may belong to a fork outside of the repository.
- Loading branch information
Showing
2 changed files
with
84 additions
and
0 deletions.
There are no files selected for viewing
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
| Original file line number | Diff line number | Diff line change |
|---|---|---|
| @@ -0,0 +1,84 @@ | ||
| ### toxSummary | ||
| * [Regulatory Toxicology and Pharmacology](https://www-sciencedirect-com.fda.idm.oclc.org/journal/regulatory-toxicology-and-pharmacology) | ||
| * impact factor: 3.59 | ||
| * [aims and scope](https://www-sciencedirect-com.fda.idm.oclc.org/journal/regulatory-toxicology-and-pharmacology/about/aims-and-scope) | ||
| * [review time](https://journalinsights.elsevier.com/journals/0273-2300/review_speed) | ||
| * Submission to first decision: 1 month | ||
| * Submission to final decision: 2 moths | ||
| * [article guideline: page 10](https://www-elsevier-com.fda.idm.oclc.org/wps/find/journaldescription.cws_home/622939?generatepdf=true) | ||
| * [Therapeutic Innovation & Regulatory Science (TIRS)](https://www.springer.com/journal/43441/) | ||
| * impact factor 1.3 | ||
| * open access fee $3390 | ||
| * word count: 5000 | ||
| * Introduction, Methods, results, conclusions | ||
| * [shiny app example](https://link.springer.com/search?query=shiny&search-within=Journal&facet-journal-id=43441) | ||
| * Springer | ||
| * Submission to first decision: 19 days | ||
| * [Journal of Pharmacological and Toxicological Methods](https://www-sciencedirect-com.fda.idm.oclc.org/journal/journal-of-pharmacological-and-toxicological-methods/about/aims-and-scope) | ||
| * impact factor 2.28 | ||
| * [Bioinformatics](https://academic.oup.com/bioinformatics/pages/instructions_for_authors) | ||
| * impact factor: 6.9 | ||
| * open access fee: 3700 | ||
| * paper: 7 pages(5000 words) | ||
| * application note: 2 pages (1300 words) | ||
| * [shiny example](https://academic.oup.com/bioinformatics/search-results?page=1&q=shiny&fl_SiteID=5139&SearchSourceType=1&allJournals=1) | ||
| * mostly gene and sequencing related app | ||
| * [BMC Bioinformatics](https://bmcbioinformatics.biomedcentral.com/submission-guidelines/aims-and-scope) | ||
| * impact factor: 4.34 | ||
| * [Frontiers in Bioinformatics](https://www.frontiersin.org/journals/bioinformatics) | ||
| * could not find Impact factor (may be bcz its new journal) | ||
| * [Data Visualization](https://www.frontiersin.org/journals/bioinformatics/sections/data-visualization) | ||
| * [Visual Informatics](https://www-sciencedirect-com.fda.idm.oclc.org/journal/visual-informatics/vol/6/issue/3) | ||
| * Citescore 5.2 | ||
|
|
||
| * some examples | ||
| * [PLOS ONE](https://journals.plos.org/plosone/s/journal-information#loc-timely-publication) | ||
| * [PLOS ONE shiny app](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0261083l) | ||
| * impact factor: 3.75 | ||
| * Time to First Editorial Decision: 15 days | ||
| * [DosePredict](https://accp1.onlinelibrary.wiley.com/doi/10.1002/jcph.1649) | ||
| * [drug safety](https://link.springer.com/journal/40264/volumes-and-issues/45-12) | ||
| * [suggestions](https://journalfinder.elsevier.com/results?elsevierOnly=true&fieldsOfResearch=&goldOpenAccess=true&keywords=&paperAbstract=Prior%20to%20initiation%20of%20clinical%20trials%2C%20repeat-dose%20toxicology%20studies%20are%20conducted%20in%20multiple%20species%20to%20support%20the%20safety%20of%20the%20active%20pharmaceutical%20ingredient%20%28API%29%20in%20the%20proposed%20clinical%20dosing%20regimen%2C%20route%20of%20administration%2C%20and%20duration%20of%20treatment.%20The%20primary%20metric%20used%20to%20extrapolate%20the%20safety%20of%20clinical%20dosage%20from%20repeat-dose%20toxicology%20study%20results%20is%20the%20safety%20margin%2C%20i.e.%20the%20ratio%20of%20no%20observable%20adverse%20effect%20level%20%28NOAEL%29%20from%20the%20toxicology%20study%20to%20the%20proposed%20clinical%20dose.%20This%20ratio%20can%20be%20calculated%20by%20using%20allometric%20scaling%20to%20approximate%20the%20equivalent%20human%20dose%20from%20that%20used%20in%20the%20toxicology%20study%20based%20on%20the%20body%20surface%20area%20of%20the%20species%20employed%20or%20by%20comparing%20the%20empirically%20measured%20maximum%20plasma%20concentration%20%28Cmax%29%20or%20total%20plasma%20exposure%20%28AUC%29%20between%20the%20toxicokinetic%20animal%20data%20and%20the%20human%20pharmacokinetic%20data%2C%20if%20available.%20Another%20important%20consideration%20in%20drug%20safety%20evaluation%20is%20the%20nature%20and%20severity%20of%20the%20toxicities%20observed%20at%20doses%20above%20the%20NOAEL.%20As%20toxicity%20studies%20of%20various%20durations%20are%20typically%20conducted%20in%20multiple%20species%20and%20potentially%20via%20multiple%20routes%20of%20administration%2C%20it%20can%20be%20challenging%20to%20effectively%20integrate%20all%20of%20this%20information.%20In%20collaboration%20with%20the%20Pharmaceutical%20Users%20Software%20Exchange%20%28PHUSE%29%20Nonclinical%20Scripts%20Working%20Group%20and%20with%20consultation%20from%20toxicologists%20at%20FDA%2C%20an%20open%20source%20software%20application%20was%20developed%20to%20allow%20users%20to%20interactively%20visualize%20safety%20margins%20and%20the%20severity%20of%20user-defined%20significant%20toxicities%20across%20studies%20throughout%20a%20drug%20development%20program%20in%20a%20single%20figure.%20The%20application%20can%20also%20present%20this%20information%20in%20tabular%20form%20that%20can%20be%20exported%20in%20various%20formats%2C%20e.g.%20CSV%2C%20Excel%20or%20Word%20files.%20These%20functionalities%20are%20designed%20to%20facilitate%20holistic%20evaluation%20of%20the%20drug%20safety%20by%20generating%20graphical%20and%20tabular%20summaries%20of%20the%20full%20toxicological%20profile%20of%20an%20API.&paperTitle=&subscription=true) | ||
|
|
||
| ### BayesianTox | ||
| * [Therapeutic Innovation & Regulatory Science (TIRS)](https://www.springer.com/journal/43441/) | ||
| * impact factor 1.3 | ||
| * open access fee $3390 | ||
| * word count: 5000 | ||
| * Introduction, Methods, results, conclusions | ||
| * [shiny app example](https://link.springer.com/search?query=shiny&search-within=Journal&facet-journal-id=43441) | ||
| * Springer | ||
| * [Regulatory Toxicology and Pharmacology](https://www-sciencedirect-com.fda.idm.oclc.org/journal/regulatory-toxicology-and-pharmacology) | ||
| * impact factor: 3.59 | ||
| * [aims and scope](https://www-sciencedirect-com.fda.idm.oclc.org/journal/regulatory-toxicology-and-pharmacology/about/aims-and-scope) | ||
| * [review time](https://journalinsights.elsevier.com/journals/0273-2300/review_speed) | ||
| * Submission to first decision: 1 month | ||
| * Submission to final decision: 2 moths | ||
| * [Computational Statistics & Data Analysis](https://www-sciencedirect-com.fda.idm.oclc.org/journal/computational-statistics-and-data-analysis) | ||
| * impact factor: 2.0 | ||
| * acceptance rate: 11% | ||
| * [Journal of Pharmacological and Toxicological Methods](https://www-sciencedirect-com.fda.idm.oclc.org/journal/journal-of-pharmacological-and-toxicological-methods) | ||
| * impact factor: 2.28 | ||
| * [Pharmaceutical Statistics](https://onlinelibrary.wiley.com/journal/15391612) | ||
| * impact factor 1.23 | ||
| * [Statistics in Medicine](https://onlinelibrary.wiley.com/journal/10970258?utm_source=wileysjf&utm_medium=web) | ||
| * impact factor: 2.497 | ||
| * [Biostatistics](https://academic.oup.com/biostatistics/pages/About) | ||
| * impact factor: 5.28 | ||
| * [BMC Bioinformatics](https://bmcbioinformatics.biomedcentral.com/submission-guidelines/aims-and-scope) | ||
| * impact factor: 4.34 | ||
|
|
||
| * [Alternatives to Laboratory animals](https://journals.sagepub.com/home/atla) | ||
| * impact factor: 2.43 | ||
|
|
||
| * [BMC Medical Research Methodology](https://bmcmedresmethodol.biomedcentral.com/) | ||
| * impact factor: 4.6 | ||
|
|
||
| ### resources: | ||
| * [checks](https://www.elsevier.com/connect/11-steps-to-structuring-a-science-paper-editors-will-take-seriously) | ||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
Binary file not shown.